First trial against pharmaceutical giant for opioid epidemic begins in Oklahoma

| May 29, 2019

article image
Pharmaceutical company Johnson & Johnson is accused of contributing to the opioid epidemic in the United States. The company reportedly denies the charges of having conducted misleading campaigns that minimised the risks of opioids and exaggerating their benefits.

Spotlight

Synergy CRO

Since 2002, SRG provides support to the pharmaceutical, biotechnology and medical device industries with a comprehensive range of collaborative services and solutions. In order to help our clients meet their clinical research goals we constantly explore and implement new ways to evolve the drug development process as well as look for cost-effective solutions. Through this work, we have come to value and respect up to date technologies along with time-tested traditional solutions. Loyalty to traditions, Openness to innovation With its unique philosophic mindset, Synergy is now the leading full-service contract research organization (CRO).

OTHER ARTICLES

3 Big Pharma Stocks Plunging the Most During the Coronavirus Stock Market Crash: Are They Buys?

Article | March 26, 2020

Big pharma stocks have been clobbered during the coronavirus-caused stock market crash. You can count the number of drugmakers with market caps of $25 billion or more whose shares haven't dropped by double-digit percentages on one hand -- and have several fingers left over. Three big pharma stocks have plunged the most: AbbVie (NYSE:ABBV), Bristol Myers Squibb (NYSE:BMY), and Pfizer (NYSE:PFE). But are these stocks smart picks to buy right now?

Read More

Enabling Active Pharma Ingredients for Batch Balancing and Integration to SAP EWM

Article | April 6, 2020

Batch and its Classification system are two most potent weapons used in Chemical, Pharma or Medical life science industry to record the potency of a batch or technically called as Active Pharma Ingredients(API). These material consist of one or more active ingredients, concentrates, carrier materials, or impurities, and so on. The potency of the active ingredients varies from batch to batch. The active ingredient is the substance of greatest interest in the bill of materials, the proportion of which may vary from batch to batch. Therefore, during creation of a process order, the system must be able to select and adjust the batches needed to obtain the required amount of active ingredient. Take an example of a drug hydroxychloroquine which is used as potent weapon to fight COVID-19. This drug is manufactured by using API, however, the Potency of this API material vary from batch to batch. To map this kind of requirement in SAP ERP, SAP calls it as Material Quantity Calculation.

Read More

Tips for Managing Chronic Pain Beyond Prescription Painkillers

Article | February 17, 2020

Painkillers like Oxycontin, Percocet, and Vicodin, have been prescribed by primary physicians, surgeons, dentists, and other healthcare providers to patients suffering from varying levels of pain. Though these medications have proven to be an effective source of pain relief, they have also proven to be highly addictive. In fact, it has even been reported that there are more cases of a drug overdose and deaths from prescription painkillers than heroin or cocaine. While there are a number of factors that play into this opioid epidemic, educating doctors and patients on alternative solutions to managing chronic pain is a great place to start combatting this nationwide crisis.

Read More

Do Clinical Trial Delays Mean Trouble for Pharmaceutical Stocks?

Article | April 1, 2020

Pharmaceutical stocks have been somewhat of a safe haven for investors as the coronavirus outbreak spread from China to the rest of the world. But as the pandemic deepened, now resulting in more than 782,000 cases worldwide, even these "safer" companies are beginning to feel the effects. The U.S. is now the coronavirus epicenter, with the most cases -- more than 161,000 as of today. Initial concerns for drugmakers had to do with the supply of active pharmaceutical ingredients, which often come from China. The worry was that pharmaceutical companies wouldn't be able to produce enough of their drugs for patients.

Read More

Spotlight

Synergy CRO

Since 2002, SRG provides support to the pharmaceutical, biotechnology and medical device industries with a comprehensive range of collaborative services and solutions. In order to help our clients meet their clinical research goals we constantly explore and implement new ways to evolve the drug development process as well as look for cost-effective solutions. Through this work, we have come to value and respect up to date technologies along with time-tested traditional solutions. Loyalty to traditions, Openness to innovation With its unique philosophic mindset, Synergy is now the leading full-service contract research organization (CRO).

Events